Ringborg U - Search Results

1

Psychological effects of participation in a prevention programme for individuals with increased risk for malignant melanoma.

Brandberg Y, Bergenmar M, Bolund C, Månsson-Brahme E, Ringborg U, Sjødén PO. Brandberg Y, et al. Among authors: ringborg u. Eur J Cancer. 1992;28A(8-9):1334-8. doi: 10.1016/0959-8049(92)90512-z. Eur J Cancer. 1992. PMID: 1515245

2

Early detection and prevention of cutaneous malignant melanoma: emphasis on Swedish activities.

Ringborg U, Lagerlöf B, Broberg M, Månsson-Brahme E, Platz A, Thörn M. Ringborg U, et al. Med Oncol Tumor Pharmacother. 1991;8(3):183-7. doi: 10.1007/BF02987178. Med Oncol Tumor Pharmacother. 1991. PMID: 1803179 Review.

3

Psychological reactions in patients with malignant melanoma.

Brandberg Y, Månsson-Brahme E, Ringborg U, Sjödén PO. Brandberg Y, et al. Among authors: ringborg u. Eur J Cancer. 1995;31A(2):157-62. doi: 10.1016/0959-8049(94)00333-z. Eur J Cancer. 1995. PMID: 7718319

4

Psychological reactions in public melanoma screening.

Brandberg Y, Bolund C, Michelson H, Månsson-Brahme E, Ringborg U, Sjödén PO. Brandberg Y, et al. Among authors: ringborg u. Eur J Cancer. 1993;29A(6):860-3. doi: 10.1016/s0959-8049(05)80425-3. Eur J Cancer. 1993. PMID: 8484978

5

Perceived susceptibility to and knowledge of malignant melanoma: screening participants vs the general population.

Brandberg Y, Bolund C, Michelson H, Mansson-Brahme E, Ringborg U, Sjödén PO. Brandberg Y, et al. Among authors: ringborg u. Prev Med. 1996 Mar-Apr;25(2):170-7. doi: 10.1006/pmed.1996.0043. Prev Med. 1996. PMID: 8860282

6

Nodular histogenetic type -- the most significant factor for thick melanoma: implications for prevention.

Bergenmar M, Ringborg U, Månsson Brahme E, Brandberg Y. Bergenmar M, et al. Among authors: ringborg u. Melanoma Res. 1998 Oct;8(5):403-11. doi: 10.1097/00008390-199810000-00004. Melanoma Res. 1998. PMID: 9835453

7

Trends in mortality from malignant melanoma in Sweden, 1970-1996.

Cohn-Cedermark G, Månsson-Brahme E, Rutqvist LE, Larsson O, Johansson H, Ringborg U. Cohn-Cedermark G, et al. Among authors: ringborg u. Cancer. 2000 Jul 15;89(2):348-55. doi: 10.1002/1097-0142(20000715)89:2<348::aid-cncr20>3.0.co;2-x. Cancer. 2000. PMID: 10918165

8

Information to patients with malignant melanoma: a randomized group study.

Brandberg Y, Bergenmar M, Bolund C, Michelson H, Månsson-Brahme E, Ringborg U, Sjödén PO. Brandberg Y, et al. Among authors: ringborg u. Patient Educ Couns. 1994 Jun;23(2):97-105. doi: 10.1016/0738-3991(94)90047-7. Patient Educ Couns. 1994. PMID: 21207908 Clinical Trial.

9

Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.

Hansson J, Bergenmar M, Hofer PA, Lundell G, Månsson-Brahme E, Ringborg U, Synnerstad I, Bratel AT, Wennberg AM, Rosdahl I. Hansson J, et al. Among authors: ringborg u. J Clin Oncol. 2007 Jul 1;25(19):2819-24. doi: 10.1200/JCO.2007.11.4108. J Clin Oncol. 2007. PMID: 17602087

10

[Telephone information about malignant melanoma is common. More patients receive information about their diagnosis at their second visit].

Brandberg Y, Bolund C, Ringborg U, Sjödén PO. Brandberg Y, et al. Among authors: ringborg u. Lakartidningen. 1995 Apr 19;92(16):1705-7. Lakartidningen. 1995. PMID: 7723488 Swedish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters